Given our finding that Fcrl5 overexpression disrupts immune tolerance, it is conceivable that Fcrl5 in anergic B cells, which are inherently restrained from autoreactive responses, may facilitate BCR signaling and precipitate autoimmune diseases. This evidence concerns the gene FCRL5 and autoimmune disease.